Shandong Weigao Group Medical Polymer Company Limited

SHSC:1066 Stock Report

Market Cap: HK$21.0b

Shandong Weigao Group Medical Polymer Past Earnings Performance

Past criteria checks 2/6

Shandong Weigao Group Medical Polymer has been growing earnings at an average annual rate of 4.2%, while the Medical Equipment industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 6.4% per year. Shandong Weigao Group Medical Polymer's return on equity is 8%, and it has net margins of 14.7%.

Key information

4.2%

Earnings growth rate

4.0%

EPS growth rate

Medical Equipment Industry Growth13.7%
Revenue growth rate6.4%
Return on equity8.0%
Net Margin14.7%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Shandong Weigao Group Medical Polymer makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SHSC:1066 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2412,9671,9123,778600
31 Mar 2413,0981,9573,807596
31 Dec 2313,2292,0023,837593
30 Sep 2313,3982,2213,793597
30 Jun 2313,5662,4403,748602
31 Mar 2313,6572,6023,721579
31 Dec 2213,7472,7643,694556
30 Sep 2213,9032,6763,725551
30 Jun 2214,0582,5893,755546
31 Mar 2213,6332,4323,793525
31 Dec 2113,2092,2763,830503
30 Sep 2112,9232,2883,865493
30 Jun 2112,6362,3003,900484
31 Mar 2112,1292,1943,775454
31 Dec 2011,6222,0873,651424
30 Sep 2011,1391,9983,636403
30 Jun 2010,6561,9093,622382
31 Mar 2010,5201,8793,699394
31 Dec 1910,3841,8503,776406
30 Sep 199,9931,8053,696374
30 Jun 199,6021,7603,615341
31 Mar 199,2051,6163,500326
31 Dec 188,8091,4733,385311
30 Jun 187,4651,2552,842280
31 Mar 186,8791,2552,593277
31 Dec 176,2931,2552,344274
30 Jun 175,4021,2971,918258
31 Mar 175,5111,1652,062262
31 Dec 165,6201,0332,206266
30 Sep 166,4841,0102,469302
30 Jun 166,2379142,367302
31 Mar 166,0781,0132,153297
31 Dec 155,9191,1131,938293
30 Sep 155,8781,2371,920290
30 Jun 155,6101,1961,839262
31 Mar 155,5481,1611,828252
31 Dec 145,2781,0851,742238
30 Sep 145,0113071,646222
30 Jun 144,9964311,583222
31 Mar 144,7693761,521215
31 Dec 134,6133881,453209

Quality Earnings: 1066 has high quality earnings.

Growing Profit Margin: 1066's current net profit margins (14.7%) are lower than last year (18%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 1066's earnings have grown by 4.2% per year over the past 5 years.

Accelerating Growth: 1066's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 1066 had negative earnings growth (-21.6%) over the past year, making it difficult to compare to the Medical Equipment industry average (-4.3%).

Return on Equity

High ROE: 1066's Return on Equity (8%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 02:45
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shandong Weigao Group Medical Polymer Company Limited is covered by 35 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason MannBarclays
Derrick SunBNP Paribas Securities (Asia)
Feng Qiang SunBOCOM International Securities Limited